Table 3.
Risk of HPV persistent infection associated with elevated levels of circulating adipokines and cytokines.
| Sample Type | ||||||
|---|---|---|---|---|---|---|
| Tertile Ranges | Control | HPV Persistent | OR | 95%CI | Ptrend | |
| Resistin | <30 | 30 | 3 | 1.0 | ||
| 30–75 | 17 | 16 | 9.4 | 2.4–37.1 | ||
| >75 | 3 | 31 | 103.3 | 19.3–552.8 | <0.0001 | |
| sFas | <6.25 | 23 | 10 | 1.0 | ||
| 6.25–7.50 | 15 | 18 | 2.8 | 1.0–7.6 | ||
| >7.50 | 12 | 22 | 4.2 | 1.5–11.7 | 0.0025 | |
| IL-8 | <30 | 31 | 2 | 1.0 | ||
| 30–300 | 12 | 21 | 27.1 | 5.5–133.8 | ||
| >300 | 7 | 27 | 59.8 | 11.4–312.5 | <0.0001 | |
| TNF-a | <8.0 | 30 | 3 | 1.0 | ||
| 8.0–60.4 | 13 | 20 | 15.4 | 3.88–61.0 | ||
| >60.4 | 7 | 27 | 38.6 | 9.1–164.3 | <0.0001 | |
Abbreviations: OR, Odd Ratios; CI, Confidence Interval